Skip to main content

Part of the book series: Cancer Treatment and Research ((CTAR,volume 91))

Abstract

It has become clear that a quality of life assessment of anticancer treatment is crucial in measuring its impact. Quality of life assessment in cancers tends to assess side effects of treatment, usually chemotherapy, and therefore contains measures that are inappropriate for the majority of extremity sarcoma patients. Although it is important to measure emotional and social factors, physical factors are also crucial. The European Organization for Research and Treatment of Cancer (EORTC) QLQC30 is a commonly used measure that evaluates pain, fatigue, emotional functions, systemic symptoms, and physical functions [1]. About 40% of its questions assess physical function, but the total score is affected by measures that are not particularly relevant to extremity sarcoma patients. It is therefore not the most appropriate instrument in this group of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aaronson NK, Bullinger M, Ahmedzai S. A modular approach to quality-of-life assessment in cancer clinical trials. Recent Results Cancer Res 111:231–249, 1988.

    Article  PubMed  CAS  Google Scholar 

  2. Abbatucci JS, Boulier N, De Ranieri J, Mandard AM, Tanguy A, Busson A. Radiotherapy as an integrated part of the treatment of soft tissue sarcomas. Radiother Oncol 2:115–121, 1984.

    Article  PubMed  CAS  Google Scholar 

  3. Eilber FR, Giuliano AE, Huth JF, Morton DL. A randomized prospective trial using postoperative adjuvant chemotherapy (Adriamycin) in high-grade extremity soft-tissue sarcoma. Am J Clin Oncol 11:39–45, 1988.

    Article  PubMed  CAS  Google Scholar 

  4. Potter DA, Kinsella T, Glatstein E, Wesley R, White DE, Seipp CA, Chang AE, Lack EE, Costa J, Rosenberg SA. High-grade soft tissue sarcomas of the extremities. Cancer 58:190–205, 1986.

    Article  PubMed  CAS  Google Scholar 

  5. Barkley HT, Jr., Martin RG, Romsdahl MM, Lindberg R, Zagars GK. Treatment of soft tissue sarcomas by preoperative irradiation and conservative surgical resection. Int J Radiat Oncol Biol Phys 14:693–699, 1988.

    Article  PubMed  Google Scholar 

  6. Suit HD, Mankin HJ, Wood WC, Gebhardt MC, Harman DC, Rosenberg A, Tepper JE, Rosenthal D. Treatment of the patient with stage Mo soft tissue sarcoma. J Clin Oncol 6:854–862, 1988.

    PubMed  CAS  Google Scholar 

  7. Robinson M, Barr L, Fisher C, Fryatt I, Stotter A, Harmer C, Wiltshaw E, Westbury G. Treatment of extremity soft tissue sarcomas with surgery and radiotherapy. Radiother Oncol 18:221–233, 1990.

    Article  PubMed  CAS  Google Scholar 

  8. Ashby MA, Ago CT, Harmer CL. Hypofractionated radiotherapy for sarcomas. Int J Radiat Oncol Biol Phys 12:13–17, 1986.

    Article  PubMed  CAS  Google Scholar 

  9. Robinson MH, Spruce L, Eeles R, Fryatt I, Harmer CL, Thomas JM, Westbury G. Limb function following conservation treatment of adult soft tissue sarcoma. Eur J Cancer 27:1567–1574, 1991.

    Article  PubMed  CAS  Google Scholar 

  10. Chang AE, Steinberg SM, Culnane M, Lampert MH, Reggia AJ, Simpson CG, Hicks JE, White DE, Yang JJ, Glatstein E, Rosenberg SA. Functional and psychosocial effects of multimodality limb-sparing therapy in patients with soft tissue sarcomas. J Clin Oncol 7:1217–1228, 1989.

    PubMed  CAS  Google Scholar 

  11. Sugarbaker PH, Barofsky I, Rosenberg SA, Gianola FJ. Quality of life assessment of patients in extremity sarcoma clinical trials. Surgery 91:17–23, 1982.

    PubMed  CAS  Google Scholar 

  12. Pittam et al. Personal Communication.

    Google Scholar 

  13. Postma A, Kingma A, De-Ruiter JH, Koops HS, Veth RPH, Goeken LNH, Kamps WA, Karakousis CP. Quality of life in bone tumour patients comparing limb salvage and amputation of lower extremity. J Surg Oncol 51:47–51, 1992.

    Article  PubMed  CAS  Google Scholar 

  14. Christ GC. The psychosocial adaptation to bone cancer diagnsoed during adolescence: A long-term follow-up study. Diss Abstract Int A 53:2545, 1993.

    Google Scholar 

  15. Lampert MH, Gerber LH, Glatstein E, Rosenberg SA, Danoff JV. Soft tissue sarcoma: Functional outcome after wide local excision and radiation therapy. Arch Phys Med Rehabil 65:477–480, 1984.

    PubMed  CAS  Google Scholar 

  16. Schipper H, Clinch J, McMurray A. Measuring the quality of life of cancer patients: The Functional Living Index-Cancer: Development and validation. J Clin Oncol 2:472–483, 1984.

    PubMed  CAS  Google Scholar 

  17. Stinson SF, DeLaney TF, Greenberg J, Yang JC, Lampert MH, Hicks JE, Venzon D, White DE, Rosenberg SA, Glatstein EJ. Acute and long term effects on limb function of combined modality limb sparing therapy for extremity soft tissue sarcoma. Int J Radiat Oncol Biol Phys 21:1493–1499, 1991.

    Article  PubMed  CAS  Google Scholar 

  18. Bell RS, O’Sullivan B, Davis A, Langer F, Cummings B, Fornasier VL. Functional outcome in patients treated with surgery and irradiation for soft tissue tumours. J Surg Oncol 48:224–231, 1991.

    Article  PubMed  CAS  Google Scholar 

  19. Zelefsky MJ, Nori D, Shiu MH, Brennan MF. Limb salvage and soft tissue sarcomas involving neurovascular structures using combined surgical resection and brachytherapy. Int J Radiat Oncol Biol Phys 19:913–918, 1990.

    Article  PubMed  CAS  Google Scholar 

  20. Convery FR, Minteer MA, Amiel D, Connett KL. Polyarticular disability: Functional assessment. Arch Phys Med Rehabil 58:494–499, 1977.

    PubMed  CAS  Google Scholar 

  21. Scranton J, Fogel ML, Erdman WR. II: Evaluation of functional levels of patients during and following rehabilitation. Arch Phys Med Rehabil 51:1–21, 1970.

    PubMed  CAS  Google Scholar 

  22. Keus RB, Rutgers EJT, Ho GH, Gortzak E, Albus-Lutter CE, Hart AAM. Limb sparing therapy of extremity soft tissue sarcomas: Treatment outcome and long-term functional results. Eur J Cancer 30A:10:1459–1463, 1994.

    Article  Google Scholar 

  23. Johnstone PA, Wexler LH, Venzon DJ, Jacobson J, Yang JC, Horowitz ME, DeLaney TF. Sarcomas of the hand and foot: Analysis of local control and functional result with combined modality therapy in extremity preservation. Int J Radiat Oncol Biol Phys 29:735–745, 1994.

    Article  PubMed  CAS  Google Scholar 

  24. Okunieff P, Suit HT, Proppe KH. Extremity preservation by combined modality treatment of sarcomas of the hand and wrist. Int J Oncol Biol Phys 12:1923–1929, 1986.

    Article  CAS  Google Scholar 

  25. Talbert ML, Zagars GK, Sherman NE, Romsdahl MM. Conservative surgery and radiation therapy for soft tissue sarcoma of the wrist, hand, ankle, and foot. Cancer 66:2482–2491, 1990.

    Article  PubMed  CAS  Google Scholar 

  26. Selch MT, Kopald KH, Ferreiro GA, Mirra JM, Parker RG, Eilber FR. Limb salvage therapy for soft tissue sarcomas of the foot. Int J Radiat Oncol Biol Phys 19(Suppl 1):124, 1990.

    Article  Google Scholar 

  27. Pitcher ME, Thomas JM. Functional compartmental resection for soft tissue sarcomas. Eur J Surg Oncol 20:441–445, 1994.

    PubMed  CAS  Google Scholar 

  28. Peat BG, Bell RS, Davis A, O’Sullivan B, Mahoney J, Manktelow RT, Bowen V, Catton C, Fornasier VL, Langer F. Wound-healing complications after soft-tissue sarcoma surgery. Plast Reconstr Surg 93:980–987, 1994.

    Article  PubMed  CAS  Google Scholar 

  29. Saddegh MK, Bauer HC. Wound complication in surgery of soft tissue sarcoma. Analysis of 103 consecutive patients managed without adjuvant therapy. Clin Orthopaed 289:247–253, 1993.

    Google Scholar 

  30. Arbeit JM, Lees DE, Corsey R, Brennan MF. Resting energy expenditure in controls and cancer patients with localized and diffuse disease. Ann Surg 199:292–298, 1984.

    Article  PubMed  CAS  Google Scholar 

  31. Nielsen OS, Cummings B, O’Sullivan B, Catton C, Bell RS, Fornasier VL. Preoperative and postoperative irradiation of soft tissue sarcomas: Effect on radiation field size. Int J Radiat Oncol Biol Phys 21:1595–1599, 1991.

    Article  PubMed  CAS  Google Scholar 

  32. Karasek K, Constine LS, Rosier R. Sarcoma therapy: Functional outcome and relationship to treatment parameters. Int J Radiat Oncol Biol Phys 24:651–656, 1992.

    Article  PubMed  CAS  Google Scholar 

  33. Weddington WW. Psychological outcomes in survivors of extremity sarcomas following amputation or limb-sparing surgery. Cancer Treat Res 56:53–60, 1991.

    Article  PubMed  CAS  Google Scholar 

  34. Lampert MH, Gahagen C. Physical therapy for the cancer patient. In CL McGarvey, ed. Rehabilitation of the Sarcoma Patient. Clinics in Physical Therapy. New York: Churchill Livingstone, 1990:111–135.

    Google Scholar 

  35. Ball ABS, Fisher C, Pittam M, Watkins RM, Westbury G. Diagnosis of soft tissue tumours by Tru-CutR biopsy. Br J Surg 77:756–758, 1990.

    Article  PubMed  CAS  Google Scholar 

  36. Stotter AT, A’Hern RP, Fisher C, Mott AF, Fallowfield ME, Westbury G. The influence of local recurrence of extremity soft tissue sarcoma on metastasis and survival. Cancer 66:1119–1129, 1990.

    Article  Google Scholar 

  37. Light KL. Immobilisation and treatment of patients receiving radiation therapy for extremity soft tissue sarcoma. Med Dosim 17:135–139, 1992.

    PubMed  CAS  Google Scholar 

  38. Schraffordt-Koops H, Lienard D, Eggermont AM, Hoekstra HJ, VanGeel BN, Lejeune FJ. Isolated limb perfusion with high-dose TNF-alpha, gamma-IFN, and mephalan in patients with unresectable soft tissue sarcomas: A highly effective limb-sparing procedure. Society of Surgical Oncology, 46th Annual Cancer Symposium in Conjunction with Society of Head and Neck Surgeons March, 1993, Los Angeles, CA, p 1.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer Science+Business Media New York

About this chapter

Cite this chapter

Robinson, M.H. (1997). Post-treatment limb function in soft tissue sarcomas. In: Verweij, J., Pinedo, H.M., Suit, H.D. (eds) Soft Tissue Sarcomas: Present Achievements and Future Prospects. Cancer Treatment and Research, vol 91. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-6121-7_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-6121-7_6

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7805-1

  • Online ISBN: 978-1-4615-6121-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics